Efficacy of zoledronate, denosumab or teriparatide in postmenopausal women with type 2 diabetes mellitus at high risk of fragility fractures: protocol of an open, blinded endpoint randomized controlled pilot trial.

Prasad, Trupti Nagendra; Bhadada, Sanjay Kumar; Singla, Veenu; Aggarwal, Neelam; Ram, Sant; Saini, Uttam Chand; Kumar, Ashok; Pal, Rimesh

Prasad, Trupti Nagendra; Bhadada, Sanjay Kumar; Singla, Veenu; Aggarwal, Neelam; Ram, Sant; Saini, Uttam Chand; Kumar, Ashok; Pal, Rimesh.

Afiliación

Prasad TN; Department of Endocrinology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Bhadada SK; Department of Endocrinology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Singla V; Department of Radiodiagnosis and Imaging, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Aggarwal N; Department of Gynaecology and Obstetrics, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Ram S; Department of Biochemistry, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Saini UC; Department of Orthopaedics, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Kumar A; National Institute of Nursing Education (NINE), Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Pal R; Department of Endocrinology, Postgraduate Institute of Medical Education and Research, Chandigarh 160012, India.

Ther Adv Endocrinol Metab ; 14: 20420188231207516, 2023.

Article en En | MEDLINE | ID: mdl-37873516

Palabras clave

denosumab; diabetic bone disease; teriparatide; type 2 diabetes mellitus; zoledronate

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Ther Adv Endocrinol Metab Año: 2023 Tipo del documento: Article País de afiliación: India

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google